PATRICIA WILLIAMS: Open Payments
NPI 1992310080 · OMAHA, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$743 in 30 payments from 10 companies in 2025. Trend: 2023 $136 · 2024 $291 · 2025 $743
Food & beverage: $743
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 5 | $185 |
| ABBVIE INC. | 9 | $138 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $122 |
| Amgen Inc. | 1 | $65 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $57 |
| Novo Nordisk Inc | 3 | $57 |
| Janssen Pharmaceuticals, Inc | 2 | $38 |
| Lilly USA, LLC | 2 | $31 |
| LEO Pharma Inc. | 2 | $30 |
| Sumitomo Pharma America, Inc. | 1 | $21 |
Products named: AIRSUPRA, CAPLYTA, QULIPTA, Kerendia, Wegovy, VRAYLAR, SPRAVATO, ANZUPGO.
Industry payments across NE — which companies pay providers there.
